Indraprastha Medical Corporation Limited

Equities

INDRAMEDCO

INE681B01017

Healthcare Facilities & Services

Delayed NSE India S.E. 03:43:35 2024-04-18 am EDT 5-day change 1st Jan Change
236.9 INR +2.51% Intraday chart for Indraprastha Medical Corporation Limited -1.48% +37.37%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
ICRA Keeps AA Rating on Indraprastha Medical's Bank Financing MT
HDFC Bank Sells 3% Stake in Indraprastha Medical for INR555 Million MT
Indraprastha Medical Corporation Limited Announces Resignation of Vikram Bhat as Non-Executive Director CI
Indraprastha Medical Corporation Limited Announces Cessation of Independent Director CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 30, 2023 CI
India to probe Apollo Hospital Delhi's alleged links to 'cash for kidneys' scandal RE
India's Apollo Hospitals' operator rejects allegation of illegal kidney transplants RE
Indraprastha Medical Corporation Limited Announces Cessation of Jasmine Shah as Non-Executive Director & Chairman CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Indraprastha Medical Corporation Limited Announces Resignation of Udit Prakash Rai as Non-Executive - Non-Independent Director CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Indraprastha Medical Corporation Limited Recommends Dividend for the Financial Year 2022-23 CI
ICRA Gives AA Rating to Indraprastha Medical's Bank Financing MT
Indraprastha Medical Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Indraprastha Medical Corporation Limited Approves Dividend on Equity Shares for the Financial Year Ended on 31 March, 2022 CI
Indraprastha Medical Corporation Limited Proposes Dividend for the Fiscal Year 2022 CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Indraprastha Medical Corporation Limited Recommends Dividend for the Financial Year 2021-2022 CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Chart Indraprastha Medical Corporation Limited
More charts
Indraprastha Medical Corporation Limited is an India-based company engaged in the healthcare business. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. The Company provides various services, such as in-patients, out-patients and clinical services. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. Indraprastha Apollo Hospitals has various specialties, such as anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics and gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, ophthalmology, plastic and reconstructive surgery, respiratory and sleep medicine, rheumatology, spine surgery, urology and andrology.
More about the company